Showing results (11-20 of 2,881) with videos related to
Sort By:
Pageof 289
Journal of the American College of Cardiology|March 12, 2004
Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failureAun Yeong Chong, Graham J Caine, Bethan Freestone, et al.Diabetes Care|November 25, 2004
Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial interventionHoong Sern Lim, Andrew D Blann, Aun Yeong Chong, et al.Circulation|September 15, 2004
Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptideAun Yeong Chong, Andrew D Blann, Jeetesh Patel, et al.Thrombosis and Haemostasis|November 8, 2005
Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular diseaseBethan Freestone, Gregory Y H Lip, Aun Yeong Chong, et al.Chest|March 15, 2008
Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failureBethan Freestone, Finn Gustafsson, Aun Yeong Chong, et al.International Journal of Cardiology|October 10, 2006
Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure studyAun Yeong Chong, Bethan Freestone, Hoong Sern Lim, et al.The American Journal of Cardiology|February 24, 2006
Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomesAun Yeong Chong, Bethan Freestone, Jeetesh Patel, et al.International Journal of Clinical Practice|October 19, 2018
The safety of NOACs in atrial fibrillation patient subgroups: A narrative reviewGregory Y H LipNature Reviews. Cardiology|July 27, 2011
The role of aspirin for stroke prevention in atrial fibrillationGregory Y H LipEuropean Heart Journal|December 22, 2012
Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?Gregory Y H LipPageof 289